Perspective Therapeutics, Inc. (CATX) › Capital ExpendituresPerspective Therapeutics, Inc. (CATX) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2011: $137.5K2012: $55.1K2013: $6.6K2014: $19.0K2015: $133.0K2016: $479.0K2017: $549.0K2018: $337.0K2019: $444.0K2020: $273.0K2021: $381.0K2022: $282.0K2023: $1.07M2024: $54.41M2025: $12.75M$12.75M2011Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$12.75M-76.6%2024$54.41M+4975.9%2023$1.07M+280.1%2022$282.0K-26.0%2021$381.0K+39.6%2020$273.0K-38.5%2019$444.0K+31.8%2018$337.0K-38.6%2017$549.0K+14.6%2016$479.0K+260.2%2015$133.0K+598.9%2014$19.0K+189.4%2013$6.6K-88.1%2012$55.1K-60.0%2011$137.5K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share